ILLUMENATE Pivotal Post-Approval Study (PAS)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.
Also called NCT03421561
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT03421561
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Austria
- Registry status
- Completed
Technical summary
Registry record NCT03421561. Randomized; double masking; primary purpose treatment. Start 2013-06-18 (actual); primary completion 2017-12-08 (actual). Results posted on 2024-02-02.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ILLUMENATE Pivotal Post-Approval Study (PAS)
- Condition
- Peripheral Artery Disease
- Intervention (Device)
- Stellarex 0.035" OTW Drug-coated Angioplasty Balloon
- Intervention (Device)
- EverCross™ 0.035 PTA Balloon Catheter
- Lead sponsor
- Spectranetics Corporation
Record details
- Record id
cardio:ct-nct03421561- Content hash
7df519459d20474f711bb59910a63be9f268df69b02cce2f664a47aafe41963a